Physician profile
Thomas Wright Nabors, III
NPI 1164433306
$972.64
in general payments reported to CMS, 2019-2025
10 companies · $15.29 in 2025
The $15.29 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.75 · 2021: $56.75 · 2022: $536 · 2023: $311 · 2024: $40.68 · 2025: $15.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $254 · Gift: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $254.04 |
| Gift | $112.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $660.74 | 2022-2023 | Opalescence |
| Abbvie INC. | $138.15 | 2023 | |
| Ortho Organizers, INC. | $42.57 | 2021 | |
| Align Technology, INC. | $32.72 | 2023 | Invisalign First - Comprehensive, Itero Element 5d Plus |
| Dentsply Sirona INC | $25.33 | 2024 | Midwest |
| Straumann USA LLC | $15.56 | 2022 | |
| Philips North America LLC | $15.35 | 2024 | (E55) Oral Health Care Und |
| Solventum Corporation | $15.29 | 2025 | 3m Clinpro |
| Dexcel Pharma Technologies Ltd. | $14.18 | 2021 | |
| Biolase, INC. | $12.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Nabors listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.